Synthetic Biology: Emerging Global Markets
This Report:- The global market for synthetic biology generated $233.8 million in 2008. This is expected to increase to $2.4 billion in 2013, for a compound annual growth rate (CAGR) of 59.8%.
- The chemicals and energy segment has the largest share of the market, worth $80.6 million in 2008. This should reach $1.6 billion in 2013, for a CAGR of 81.6%.
- The biotechnology and pharmaceuticals segment is the second-largest market segment, worth 80.3 million in 2008. This segment is projected to increase at a CAGR of 49.2% to reach $594 million in 2013.
Table of Contents
CHAPTER ONE: INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY
INFORMATION SOURCES
RELATED BCC REPORTS
ANALYST CREDENTIALS
BCC ONLINE SERVICES
DISCLAIMER
CHAPTER TWO: SUMMARY
SUMMARY
SUMMARY TABLE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY, THROUGH 2013 ($ MILLIONS)
SUMMARY FIGURE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY, 2006-2013 ($ MILLIONS)
SUMMARY (CONTINUED)
CHAPTER THREE: OVERVIEW
SYNTHETIC BIOLOGY TECHNOLOGIES COVERED IN THIS REPORT
TABLE 1 SCOPE OF THIS REPORT
WHAT IS SYNTHETIC BIOLOGY?
WHAT IS SYNTHETIC BIOLOGY (CONTINUED)
DEVELOPMENT STAGE OF SYNTHETIC BIOLOGY
FORCES DRIVING SYNTHETIC BIOLOGY MARKET GROWTH
TABLE 2 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
TABLE 2 (CONTINUED)
GLOBAL MARKET POTENTIAL FOR SYNTHETIC BIOLOGY PRODUCTS
TABLE 3 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER, THROUGH 2013 ($ MILLIONS)
TABLE 4 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BY FUEL TYPE, THROUGH 2013 ($ MILLIONS)
LIFE CYCLE STATUS OF SYNTHETIC BIOLOGY TECHNOLOGIES
TABLE 5 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
THE SYNTHETIC BIOLOGY INDUSTRY
TABLE 6 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
THE SYNTHETIC BIOLOGY INDUSTRY (CONTINUED)
CHAPTER FOUR: SYNTHETIC BIOLOGY TECHNOLOGIES
INTRODUCTION
DEFINITION OF SYNTHETIC BIOLOGY
TABLE 7 SYNTHETIC BIOLOGY DEFINITIONS
HISTORY OF SYNTHETIC BIOLOGY
TABLE 8 SYNTHETIC BIOLOGY HISTORY
PARADIGM SHIFT IN BIOLOGY
TABLE 9 PARADIGM SHIFT OF BIOLOGY
TABLE 10 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPARED
FIGURE 1 SCALE OF SYNTHETIC BIOLOGY
SYNTHETIC BIOLOGY TECHNOLOGY OVERVIEW
TABLE 11 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGY
ENABLING TECHNOLOGIES
TABLE 12 IMPORTANCE OF ENABLING TECHNOLOGIES
COSTS OF DNA SYNTHESIS AND SEQUENCING
FIGURE 2 DNA SYNTHESIS AND SEQUENCING COSTS, 1990-2008 ($)
FIGURE 3 HUMAN GENOME SEQUENCING COSTS, 1990-2015 ($)
DNA SYNTHESIS TECHNOLOGIES
FIGURE 4 SIMPLIFIED SCHEMATIC OF GENE SYNTHESIS TECHNOLOGY
DNA Synthesis … (Continued)
TABLE 13 COMPARISON OF GENE SYNTHESIS TECHNOLOGIES
PCR-Based Approaches
Solid-Phase Approaches
MICROFLUIDICS TECHNOLOGIES
TABLE 14 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETIC BIOLOGY
DNA Microarrays—Oligos Synthesis
TABLE 15 MICROARRAY TYPES
TABLE 16 DNA MICROARRAY PLATFORM FEATURES
TABLE 17 DNA MICROARRAY PLATFORM COMPARISON FOR MAJOR MANUFACTURERS
TABLE 17 (CONTINUED)
DNA Microarrays—…(Continued)
FIGURE 5 MICROARRAYS IN GENE SYNTHESIS
DNA SEQUENCING TECHNOLOGIES
DNA Sequencing TECHNOLOGIES (continued)
FIGURE 6 SEQUENCING THROUGHPUT TREND, 1977-2008
FIGURE 7 DNA SEQUENCING TECHNOLOGIES
BIOINFORMATICS TECHNOLOGIES
TABLE 18 SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIES
BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS TECHNOLOGIES
TABLE 19 NUCLEIC ACIDS, GENES, AND GENOMES
SYNTHETIC GENES
TABLE 20 SYNTHETIC GENES AS MOLECULAR BIOLOGY TOOL
Synthetic Genes (Continued)
TABLE 21 SYNTHETIC GENES VERSUS PCR CLONING
BIOBRICKS/IGEM PARTS
TABLE 22 BIOBRICKS/IGEM PARTS
FIGURE 8 ROLE OF PROMOTERS AND REPORTERS IN SYNTHETIC BIOLOGY SYSTEMS
MINIMAL GENOMES AND CHASSIS ORGANISMS
TABLE 23 ATTRIBUTES OF A MINIMAL GENOME
Minimal Genomes and … (Continued)
CASE STUDY: MINIMAL E.COLI GENOME
Role of Directed Evolution in Designing Biologic Parts
ENABLED TECHNOLOGIES
OVERVIEW
TABLE 24 ENABLED TECHNOLOGIES: EXISTING AND NEAR-TERM APPLICATIONS
Pathway Engineering
FIGURE 9 HOW SYNTHETIC BIOLOGY CREATES ENABLED PRODUCTS
TABLE 25 METABOLIC ENGINEERING FOR ARTEMISINIC ACID
Synthetic Microbial Consortia
TABLE 26 APPLICATIONS FOR SYNTHETIC MICROBIAL CONSORTIA
BIOFUELS TECHNOLOGIES
Biofuels Feedstocks
TABLE 27 ENERGY BALANCE OF SELECTED FIRST-GENERATION BIOFUEL FEEDSTOCKS
Advanced-Generation Biofuels
TABLE 28 FIRST- AND ADVANCED-GENERATION BIOFUELS COMPARED
Cellulosic Biomass
FIGURE 10 APPROXIMATE COMPOSITION OF CELLULOSIC BIOMASS (%)
TABLE 29 SYNTHETIC BIOLOGY STRATEGIES FOR CONVERTING CELLULOSIC BIOMASS INTO ETHANOL
Biofuels Types
TABLE 30 EFFICIENCY OF VARIOUS FUELS
Cellulosic Ethanol
FIGURE 11 CELLULOSIC ETHANOL PRODUCTION SCHEMATIC
TABLE 31 CORN ETHANOL COST TARGETS, 2009 ($/GAL. OF ETHANOL)
FIGURE 12 ESTIMATED 25 MGY CELLULOSIC ETHANOL PLANT COSTS (%)
Biodiesel
TABLE 32 IODINE NUMBER OF VARIOUS OILS
Other Biofuels
Role of Genetic Engineering and Synthetic Biology in Biofuels
TABLE 33 CONTRIBUTION OF SYNTHETIC BIOLOGY TO BIOFUELS
CHAPTER FIVE: SYNTHETIC BIOLOGY APPLICATIONS
INTRODUCTION
ENABLING TECHNOLOGIES
TABLE 34 SYNTHETIC BIOLOGY PRODUCTS IMPACTED BY ENABLING TECHNOLOGIES
BIOLOGIC COMPONENTS AND INTEGRATED SYSTEMS APPLICATIONS
TABLE 35 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS NEAR-TERM APPLICATIONS
SYNTHETIC GENE APPLICATIONS
TABLE 36 SYNTHETIC GENES NEAR-TERM APPLICATIONS
Synthetic Gene Applications (Continued)
Synthetic Gene Applications (Continued)
BIOBRICKS/IGEM PARTS APPLICATIONS
INTEGRATED SYSTEMS APPLICATIONS
Synthetic Cells and Tissues
ENABLED PRODUCTS APPLICATIONS
TABLE 37 ENABLED PRODUCTS NEAR-TERM APPLICATIONS
APPLICATIONS BY END-USER INDUSTRY
RESEARCH AND DEVELOPMENT APPLICATIONS
TABLE 38 RESEARCH & DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS
PHARMACEUTICALS APPLICATIONS
TABLE 39 DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS
Pharmaceuticals Applications (Continued)
TABLE 40 PIPELINE OF SYNTHETIC BIOLOGY-ENABLED DRUGS
ENERGY APPLICATIONS
TABLE 41 ETHANOL AND BIODIESEL FEEDSTOCKS AND PRODUCTION PROCESSES
TABLE 42 ETHANOL AND BIODIESEL COMMON BLENDS
TABLE 43 FIRST-GENERATION FUEL ETHANOL GLOBAL PRODUCTION AND GOALS, 2007 (MILLION GALS.)
TABLE 44 FIRST-GENERATION BIODIESEL PRODUCTION AND GOALS, 2007 (MILLION GALS.)
United States
FIGURE 13 RENEWABLE FUELS STANDARDS, UNITED STATES, 2008-2013 (BILLION GALS./ YR)
TABLE 45 DOE FUNDING FOR CELLULOSIC BIOFUELS, 2007-2011 ($ MILLIONS)
Canada
Brazil
CHEMICAL INDUSTRY APPLICATIONS
Chemical Industry Applications (Continued)
CHAPTER SIX: SYNTHETIC BIOLOGY INDUSTRY
INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN
FIGURE 14 INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN WITH SYNTHETIC BIOLOGY LEVERAGE POINTS
INDUSTRY STRUCTURAL FORCES
TABLE 46 SYNTHETIC BIOLOGY INDUSTRY STRUCTURAL FORCES
INDUSTRY STRUCTURAL FORCES (CONTINUED)
PRODUCTS AND TECHNOLOGY LIFE CYCLE
TABLE 47 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
INDUSTRY COMPETITOR POSITIONING
TABLE 48 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
GENE SYNTHESIS INDUSTRY
GENE SYNTHESIS WORKFLOW
TABLE 49 GENE SYNTHESIS WORKFLOW
Gene Synthesis Workflow (Continued)
GENE SYNTHESIS COMPETITOR STRATEGIES
FIGURE 15 SYNTHETIC GENE COMPANY ESTIMATED MARKET SHARES, 2008 (%)
Gene Synthesis … (Continued)
TABLE 50 SYNTHETIC GENE KEY COMPETITOR STRATEGIES
Gene Synthesis … (Continued)
Gene Synthesis Value Chain
Synthetic Gene Market Segments
Automated, Standardized Market Segment
Value-Added Market Segments
TABLE 51 GENE SYNTHESIS MARKET FACTORS OF DIFFERENTIATION
BIOFUELS INDUSTRY
COMPETITIVE DIFFERENTIATION
FEEDSTOCKS
TABLE 52 BIOFUELS: FEEDSTOCKS, PRODUCTION, AND PRODUCTS
FIGURE 16 BIOFUELS FEEDSTOCKS: RELATIVE COSTS AND VOLUMES
Sugars/Starches
Vegetable Oils
Biomass
Algae
TABLE 53 BIODIESEL YIELD OF SELECTED CROPS (GALS./ACRE/YR.)
CO2
CELLULOSIC ETHANOL INDUSTRY
TABLE 54 CELLULOSIC ETHANOL PLANTS (MGY)
Cellulosic Ethanol Industry (Continued)
BIOFUELS COMPETITOR STRATEGIES
TABLE 55 SYNTHETIC BIOLOGY-BASED BIOFUELS COMPANY STRATEGIES
TABLE 55 (CONTINUED)
Agrivida
Amyris
BP 116
DuPont
Gevo
LS9
Mascoma
OpX Biotechnologies
Sequesco
Solazyme
Synthetic Genomics
Verdezyne
Verenium
ROLE OF BIOFUELS FOUNDERS AND INVESTORS
TABLE 56 ROLE OF INVESTORS AND FOUNDERS IN BIOFUELS COMPANIES
ENZYMES INDUSTRY
TABLE 57 ENZYME COMPANY KEY ALLIANCES
PHARMACEUTICALS INDUSTRY
TABLE 58 PHARMACEUTICALS COMPANY STRATEGIES
INDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCES
TABLE 59 INDUSTRY ACQUISITIONS, 2006-2008
TABLE 60 SYNTHETIC BIOLOGY STRATEGIC ALLIANCES, 2006-2009
TABLE 60 (CONTINUED)
TABLE 60 (CONTINUED)
BIODEFENSE ISSUES
TABLE 61 FUTURE SYNTHETIC BIOLOGY SECURITY REGULATIONS
SUPPORTING INDUSTRY ORGANIZATIONS
TABLE 62 SYNTHETIC BIOLOGY ENABLING ORGANIZATIONS
TABLE 62 (CONTINUED)
SUPPORTING INDUSTRY … (CONTINUED)
FIGURE 17 GROWTH IN IGEM (NUMBER)
CHAPTER SEVEN: SYNTHETIC BIOLOGY MARKETS
GROWTH DRIVING FORCES
TABLE 63 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
FIGURE 18 NIH BUDGET OUTLAYS, 2000-2009 ($ BILLIONS)
FIGURE 19 SYNTHETIC BIOLOGY RESEARCH PUBLICATIONS, 2000-2008 (NUMBER)
MARKET FORECASTS
FIGURE 20 MARKET FORECAST SCENARIO TABLE
SYNTHETIC BIOLOGY MARKETS BY INDUSTRY
Summary
TABLE 64 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER, THROUGH 2013 ($ MILLIONS)
R&D Market
TABLE 65 GLOBAL VALUE OF R&D MARKET BY APPLICATION, THROUGH 2013 ($ MILLIONS)
Biotechnology and Pharmaceuticals Market
TABLE 66 GLOBAL VALUE OF BIOTECHNOLOGY AND PHARMACEUTICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
Chemicals Market
TABLE 67 GLOBAL VALUE OF CHEMICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
Energy Market
TABLE 68 GLOBAL VALUE OF ENERGY MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
FIGURE 21 S-CURVE FOR SECOND-GENERATION BIOFUELS
TABLE 69 WORLD BIODIESEL PRODUCTION AND CAPACITY TRENDS, 2002-2008 (MILLIONS TONS/YR)
TABLE 70 GLOBAL BIOFUELS SUPPLY BY PRODUCT CLASS, THROUGH 2013 (KBOED)
FIGURE 22 GLOBAL BIOFUELS MARKET, 2013 (GALS./YR.)
FIGURE 22 (CONTINUED)
FIGURE 23 GLOBAL CELLULOSIC SECOND-GENERATION BIOFUELS MARKET, 2013 (GALS./YR)
FIGURE 23 (CONTINUED)
FIGURE 24 UNITED STATES BIOFUELS MARKET GOALS, 2022 (%)
SYNTHETIC BIOLOGY MARKETS BY PRODUCT TYPE
Summary
TABLE 71 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
Summary (Continued)
Enabling Products Market
TABLE 72 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLING PRODUCTS MARKET, THROUGH 2013 ($ MILLIONS)
Biological Parts Market
TABLE 73 GLOBAL VALUE OF DNA SYNTHESIS MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 74 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
Standardized Market Segment
Value-Added Market Segments
TABLE 75 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY END USER INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 76 GLOBAL VALUE OF BIOLOGIC PARTS BY SUPPLIER TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 77 HOMEBREW VERSUS COMMERCIAL COST COMPARISON FOR SYNTHESIZING A TYPICAL 714 BP GFP GENE ($)
Integrated Systems Market
TABLE 78 GLOBAL VALUE OF SYNTHETIC BIOLOGY INTEGRATED SYSTEMS MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
Enabled Products Market
TABLE 79 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED PRODUCTS MARKET BY INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 80 GLOBAL VALUE OF ENABLED R&D MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 81 GLOBAL VALUE OF ENABLED PHARMACEUTICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 82 GLOBAL VALUE OF ENABLED CHEMICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 82 (CONTINUED)
TABLE 83 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BY FUEL TYPE, THROUGH 2013 ($ MILLIONS)
SYNTHETIC BIOLOGY MARKET BY GEOGRAPHIC REGION
Summary
TABLE 84 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY GEOGRAPHIC REGION, THROUGH 2013 ($ MILLIONS)
Importance of Geography to Fuels Markets
Importance of Geography … (Continued)
CHAPTER EIGHT: PATENT STATUS
INTRODUCTION
FOUNDATIONAL PATENTS
TABLE 85 SYNTHETIC BIOLOGY FOUNDATIONAL PATENTS
SYNTHETIC BIOLOGY INDUSTRY PATENT ANALYSIS
SYNTHETIC BIOLOGY INDUSTRY (continued)
FIGURE 25 NUMBER OF PATENTS BY COMPANY
FIGURE 25 (CONTINUED)
TABLE 86 PATENT DESCRIPTION BY COMPANY
FIGURE 26 SYNTHETIC BIOLOGY PATENTS BY COMPANY AND SUBCLASS (NUMBER OF PATENTS)
FIGURE 26 (CONTINUED)
LITIGATION STATUS
TABLE 87 IP LITIGATION STATUS
IP STRATEGY OF SELECTED SYNTHETIC BIOLOGY COMPANIES
METABOLIX
DUPONT
GENEART
FEBIT
CHAPTER NINE: COMPANY PROFILES
AGRIVIDA
AMYRIS BIOTECHNOLOGIES, INC.
TABLE 88 AMYRIS BIODIESEL ADVANTAGES
ATG BIOSYNTHETICS GMBH
BASF AG
BIO BASIC, INC.
BIOCAT GMBH
BIONEER CORP.
BIONEXUS, INC.
BIO S&T, INC.
BIOTICA TECHNOLOGY, LTD.
BIOTICA TECHNOLOGY, LTD. (CONTINUED)
TABLE 89 STRUCTURE-FUNCTION APPROACH FOR RAPAMYCIN
TABLE 90 BIOTICA PROJECTS PIPELINE
BLUE HERON BIOTECHNOLOGIES
BRISTOL-MYERS SQUIBB
BRISTOL-MYERS SQUIBB (CONTINUED)
BRITISH PETROLEUM
CELLICON BIOTECHNOLOGIES, INC.
CODEXIS, INC
CODON DEVICES, INC.
DANISCO A/S
DNA 2.0
TABLE 91 DNA2.0 STRATEGIC ALLIANCES
DRATHS CORP
DUPONT
DUPONT (CONTINUED)
DYADIC INTERNATIONAL, INC.
ENTELECHON GMBH
EPOCH BIOLABS, INC.
ERAGEN BIOSCIENCES, INC.
EUROFINS MEDIGENOMIX GMBH
EUROFINS MWG OPERON
FEBIT SYNBIO GMBH
GENEART AG
TABLE 92 GENEART MAJOR STRATEGIC ALLIANCES
GENEART AG (CONTINUED)
GENEMED SYNTHESIS, INC.
GENSCRIPT CORP.
GENEWORKS PTY, LTD.
GEVO, INC.
TABLE 93 GEVO ISOBUTANOL PRODUCTION FORECAST (GALS./YR.)
HELICOS BIOSCIENCES CORP.
HELICOS BIOSCIENCES CORP. (CONTINUED)
HELICOS BIOSCIENCES CORP. (CONTINUED)
INTEGRATED DNA TECHNOLOGIES
ILLUMINA, INC.
ILLUMINA, INC. (CONTINUED)
INSTITUTE FOR ONEWORLD HEALTH
IOGEN CORP.
JOULE BIOTECHNOLOGIES, INC.
KHOSLA VENTURES
TABLE 94 KHOSLA VENTURES BIOFUELS INVESTMENT PORTFOLIO
LC SCIENCES
LIFE TECHNOLOGIES
LIFE TECHNOLOGIES (CONTINUED)
LS9, INC.
MASCOMA
TABLE 95 MASCOMA INTELLECTUAL PROPERTY STATUS
MAXYGEN
MERCK & CO.
METABOLIX, INC.
TABLE 96 METABOLOMIX BUSINESS STRATEGY
METRIGEN, INC.
NOVOZYMES A/S
OMEGA BIO-TEK, INC.
OPX BIOTECHNOLOGIES, INC.
PACIFIC BIOSCIENCES
PFIZER
PROTOLIFE SRL
QTEROS
ROCHE LIFE SCIENCES
ROCHE LIFE SCIENCES (CONTINUED)
ROYAL DSM N.V.
SANGAMO BIOSCIENCES, INC.
SANGAMO BIOSCIENCES, INC. (CONTINUED)
SANOFI AVENTIS
SCARAB GENOMICS, LLC
SEQUESCO
SLONING BIOTECHNOLOGY, GMBH
SOLAZYME, INC.
TABLE 97 SOLAZYME STRATEGIC ALLIANCES
SYNTHETIC GENOMICS
SYNTHETIC GENOMICS (CONTINUED)
TABLE 98 SYNTHETIC GENOMICS STRATEGIC ALLIANCES
VERDEZYNE
TABLE 99 VERDEZYNE STRATEGIC COLLABORATIONS
VERENIUM CORP.
VERENIUM CORP. (CONTINUED)
LIST OF TABLES
SUMMARY TABLE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 1 SCOPE OF THIS REPORT
TABLE 2 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
TABLE 3 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER, THROUGH 2013 ($ MILLIONS)
TABLE 4 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BY FUEL TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 5 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
TABLE 6 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
TABLE 7 SYNTHETIC BIOLOGY DEFINITIONS
TABLE 8 SYNTHETIC BIOLOGY HISTORY
TABLE 9 PARADIGM SHIFT OF BIOLOGY
TABLE 10 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPARED
TABLE 11 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGY
TABLE 12 IMPORTANCE OF ENABLING TECHNOLOGIES
TABLE 13 COMPARISON OF GENE SYNTHESIS TECHNOLOGIES
TABLE 14 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETIC BIOLOGY
TABLE 15 MICROARRAY TYPES
TABLE 16 DNA MICROARRAY PLATFORM FEATURES
TABLE 17 DNA MICROARRAY PLATFORM COMPARISON FOR MAJOR MANUFACTURERS
TABLE 18 SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIES
TABLE 19 NUCLEIC ACIDS, GENES, AND GENOMES
TABLE 20 SYNTHETIC GENES AS MOLECULAR BIOLOGY TOOL
TABLE 21 SYNTHETIC GENES VERSUS PCR CLONING
TABLE 22 BIOBRICKS/IGEM PARTS
TABLE 23 ATTRIBUTES OF A MINIMAL GENOME
TABLE 24 ENABLED TECHNOLOGIES: EXISTING AND NEAR-TERM APPLICATIONS
TABLE 25 METABOLIC ENGINEERING FOR ARTEMISINIC ACID
TABLE 26 APPLICATIONS FOR SYNTHETIC MICROBIAL CONSORTIA
TABLE 27 ENERGY BALANCE OF SELECTED FIRST-GENERATION BIOFUEL FEEDSTOCKS
TABLE 28 FIRST- AND ADVANCED-GENERATION BIOFUELS COMPARED
TABLE 29 SYNTHETIC BIOLOGY STRATEGIES FOR CONVERTING CELLULOSIC BIOMASS INTO ETHANOL
TABLE 30 EFFICIENCY OF VARIOUS FUELS
TABLE 31 CORN ETHANOL COST TARGETS, 2009 ($/GAL. OF ETHANOL)
TABLE 32 IODINE NUMBER OF VARIOUS OILS
TABLE 33 CONTRIBUTION OF SYNTHETIC BIOLOGY TO BIOFUELS
TABLE 34 SYNTHETIC BIOLOGY PRODUCTS IMPACTED BY ENABLING TECHNOLOGIES
TABLE 35 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS NEAR-TERM APPLICATIONS
TABLE 36 SYNTHETIC GENES NEAR-TERM APPLICATIONS
TABLE 37 ENABLED PRODUCTS NEAR-TERM APPLICATIONS
TABLE 38 RESEARCH & DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS
TABLE 39 DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS
TABLE 40 PIPELINE OF SYNTHETIC BIOLOGY-ENABLED DRUGS
TABLE 41 ETHANOL AND BIODIESEL FEEDSTOCKS AND PRODUCTION PROCESSES
TABLE 42 ETHANOL AND BIODIESEL COMMON BLENDS
TABLE 43 FIRST-GENERATION FUEL ETHANOL GLOBAL PRODUCTION AND GOALS, 2007 (MILLION GALS.)
TABLE 44 FIRST-GENERATION BIODIESEL PRODUCTION AND GOALS, 2007 (MILLION GALS.)
TABLE 45 DOE FUNDING FOR CELLULOSIC BIOFUELS, 2007-2011 ($ MILLIONS)
TABLE 46 SYNTHETIC BIOLOGY INDUSTRY STRUCTURAL FORCES
TABLE 47 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
TABLE 48 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
TABLE 49 GENE SYNTHESIS WORKFLOW
TABLE 50 SYNTHETIC GENE KEY COMPETITOR STRATEGIES
TABLE 51 GENE SYNTHESIS MARKET FACTORS OF DIFFERENTIATION
TABLE 52 BIOFUELS: FEEDSTOCKS, PRODUCTION, AND PRODUCTS
TABLE 53 BIODIESEL YIELD OF SELECTED CROPS (GALS./ACRE/YR.)
TABLE 54 CELLULOSIC ETHANOL PLANTS (MGY)
TABLE 55 SYNTHETIC BIOLOGY-BASED BIOFUELS COMPANY STRATEGIES
TABLE 56 ROLE OF INVESTORS AND FOUNDERS IN BIOFUELS COMPANIES
TABLE 57 ENZYME COMPANY KEY ALLIANCES
TABLE 58 PHARMACEUTICALS COMPANY STRATEGIES
TABLE 59 INDUSTRY ACQUISITIONS, 2006-2008
TABLE 60 SYNTHETIC BIOLOGY STRATEGIC ALLIANCES, 2006-2009
TABLE 61 FUTURE SYNTHETIC BIOLOGY SECURITY REGULATIONS
TABLE 62 SYNTHETIC BIOLOGY ENABLING ORGANIZATIONS
TABLE 63 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
TABLE 64 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER, THROUGH 2013 ($ MILLIONS)
TABLE 65 GLOBAL VALUE OF R&D MARKET BY APPLICATION, THROUGH 2013 ($ MILLIONS)
TABLE 66 GLOBAL VALUE OF BIOTECHNOLOGY AND PHARMACEUTICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 67 GLOBAL VALUE OF CHEMICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 68 GLOBAL VALUE OF ENERGY MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 69 WORLD BIODIESEL PRODUCTION AND CAPACITY TRENDS, 2002-2008 (MILLIONS TONS/YR)
TABLE 70 GLOBAL BIOFUELS SUPPLY BY PRODUCT CLASS, THROUGH 2013 (KBOED)
TABLE 71 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 72 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLING PRODUCTS MARKET, THROUGH 2013 ($ MILLIONS)
TABLE 73 GLOBAL VALUE OF DNA SYNTHESIS MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 74 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 75 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY END USER INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 76 GLOBAL VALUE OF BIOLOGIC PARTS BY SUPPLIER TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 77 HOMEBREW VERSUS COMMERCIAL COST COMPARISON FOR SYNTHESIZING A TYPICAL 714 BP GFP GENE ($)
TABLE 78 GLOBAL VALUE OF SYNTHETIC BIOLOGY INTEGRATED SYSTEMS MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 79 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED PRODUCTS MARKET BY INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 80 GLOBAL VALUE OF ENABLED R&D MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 81 GLOBAL VALUE OF ENABLED PHARMACEUTICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 82 GLOBAL VALUE OF ENABLED CHEMICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 83 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BY FUEL TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 84 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY GEOGRAPHIC REGION, THROUGH 2013 ($ MILLIONS)
TABLE 85 SYNTHETIC BIOLOGY FOUNDATIONAL PATENTS
TABLE 86 PATENT DESCRIPTION BY COMPANY
TABLE 87 IP LITIGATION STATUS
TABLE 88 AMYRIS BIODIESEL ADVANTAGES
TABLE 89 STRUCTURE-FUNCTION APPROACH FOR RAPAMYCIN
TABLE 90 BIOTICA PROJECTS PIPELINE
TABLE 91 DNA2.0 STRATEGIC ALLIANCES
TABLE 92 GENEART MAJOR STRATEGIC ALLIANCES
TABLE 93 GEVO ISOBUTANOL PRODUCTION FORECAST (GALS./YR.)
TABLE 94 KHOSLA VENTURES BIOFUELS INVESTMENT PORTFOLIO
TABLE 95 MASCOMA INTELLECTUAL PROPERTY STATUS
TABLE 96 METABOLOMIX BUSINESS STRATEGY
TABLE 97 SOLAZYME STRATEGIC ALLIANCES
TABLE 98 SYNTHETIC GENOMICS STRATEGIC ALLIANCES
TABLE 99 VERDEZYNE STRATEGIC COLLABORATIONS
LIST OF FIGURES
SUMMARY FIGURE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY, 2006-2013 ($ MILLIONS)
FIGURE 1 SCALE OF SYNTHETIC BIOLOGY
FIGURE 2 DNA SYNTHESIS AND SEQUENCING COSTS, 1990-2008 ($)
FIGURE 3 HUMAN GENOME SEQUENCING COSTS, 1990-2015 ($)
FIGURE 4 SIMPLIFIED SCHEMATIC OF GENE SYNTHESIS TECHNOLOGY
FIGURE 5 MICROARRAYS IN GENE SYNTHESIS
FIGURE 6 SEQUENCING THROUGHPUT TREND, 1977-2008
FIGURE 7 DNA SEQUENCING TECHNOLOGIES
FIGURE 8 ROLE OF PROMOTERS AND REPORTERS IN SYNTHETIC BIOLOGY SYSTEMS
FIGURE 9 HOW SYNTHETIC BIOLOGY CREATES ENABLED PRODUCTS
FIGURE 10 APPROXIMATE COMPOSITION OF CELLULOSIC BIOMASS (%)
FIGURE 11 CELLULOSIC ETHANOL PRODUCTION SCHEMATIC
FIGURE 12 ESTIMATED 25 MGY CELLULOSIC ETHANOL PLANT COSTS (%)
FIGURE 13 RENEWABLE FUELS STANDARDS, UNITED STATES, 2008-2013 (BILLION GALS./ YR)
FIGURE 14 INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN WITH SYNTHETIC BIOLOGY LEVERAGE POINTS
FIGURE 15 SYNTHETIC GENE COMPANY ESTIMATED MARKET SHARES, 2008 (%)
FIGURE 16 BIOFUELS FEEDSTOCKS: RELATIVE COSTS AND VOLUMES
FIGURE 17 GROWTH IN IGEM
FIGURE 18 NIH BUDGET OUTLAYS, 2000-2009 ($ BILLIONS)
FIGURE 19 SYNTHETIC BIOLOGY RESEARCH PUBLICATIONS, 2000-2008 (NUMBER)
FIGURE 20 MARKET FORECAST SCENARIO TABLE
FIGURE 21 S-CURVE FOR SECOND-GENERATION BIOFUELS
FIGURE 22 GLOBAL BIOFUELS MARKET, 2013 (GALS./YR.)
FIGURE 23 2013 GLOBAL CELLULOSIC SECOND-GENERATION BIOFUELS MARKET (GALS./YR)
FIGURE 24 UNITED STATES BIOFUELS MARKET GOALS, 2022 (%)
FIGURE 25 NUMBER OF PATENTS BY COMPANY
FIGURE 26 SYNTHETIC BIOLOGY PATENTS BY COMPANY AND SUBCLASS (NUMBER OF PATENTS)
Latest Market Research Reports:
CHAPTER ONE: INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY
INFORMATION SOURCES
RELATED BCC REPORTS
ANALYST CREDENTIALS
BCC ONLINE SERVICES
DISCLAIMER
CHAPTER TWO: SUMMARY
SUMMARY
SUMMARY TABLE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY, THROUGH 2013 ($ MILLIONS)
SUMMARY FIGURE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY, 2006-2013 ($ MILLIONS)
SUMMARY (CONTINUED)
CHAPTER THREE: OVERVIEW
SYNTHETIC BIOLOGY TECHNOLOGIES COVERED IN THIS REPORT
TABLE 1 SCOPE OF THIS REPORT
WHAT IS SYNTHETIC BIOLOGY?
WHAT IS SYNTHETIC BIOLOGY (CONTINUED)
DEVELOPMENT STAGE OF SYNTHETIC BIOLOGY
FORCES DRIVING SYNTHETIC BIOLOGY MARKET GROWTH
TABLE 2 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
TABLE 2 (CONTINUED)
GLOBAL MARKET POTENTIAL FOR SYNTHETIC BIOLOGY PRODUCTS
TABLE 3 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER, THROUGH 2013 ($ MILLIONS)
TABLE 4 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BY FUEL TYPE, THROUGH 2013 ($ MILLIONS)
LIFE CYCLE STATUS OF SYNTHETIC BIOLOGY TECHNOLOGIES
TABLE 5 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
THE SYNTHETIC BIOLOGY INDUSTRY
TABLE 6 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
THE SYNTHETIC BIOLOGY INDUSTRY (CONTINUED)
CHAPTER FOUR: SYNTHETIC BIOLOGY TECHNOLOGIES
INTRODUCTION
DEFINITION OF SYNTHETIC BIOLOGY
TABLE 7 SYNTHETIC BIOLOGY DEFINITIONS
HISTORY OF SYNTHETIC BIOLOGY
TABLE 8 SYNTHETIC BIOLOGY HISTORY
PARADIGM SHIFT IN BIOLOGY
TABLE 9 PARADIGM SHIFT OF BIOLOGY
TABLE 10 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPARED
FIGURE 1 SCALE OF SYNTHETIC BIOLOGY
SYNTHETIC BIOLOGY TECHNOLOGY OVERVIEW
TABLE 11 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGY
ENABLING TECHNOLOGIES
TABLE 12 IMPORTANCE OF ENABLING TECHNOLOGIES
COSTS OF DNA SYNTHESIS AND SEQUENCING
FIGURE 2 DNA SYNTHESIS AND SEQUENCING COSTS, 1990-2008 ($)
FIGURE 3 HUMAN GENOME SEQUENCING COSTS, 1990-2015 ($)
DNA SYNTHESIS TECHNOLOGIES
FIGURE 4 SIMPLIFIED SCHEMATIC OF GENE SYNTHESIS TECHNOLOGY
DNA Synthesis … (Continued)
TABLE 13 COMPARISON OF GENE SYNTHESIS TECHNOLOGIES
PCR-Based Approaches
Solid-Phase Approaches
MICROFLUIDICS TECHNOLOGIES
TABLE 14 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETIC BIOLOGY
DNA Microarrays—Oligos Synthesis
TABLE 15 MICROARRAY TYPES
TABLE 16 DNA MICROARRAY PLATFORM FEATURES
TABLE 17 DNA MICROARRAY PLATFORM COMPARISON FOR MAJOR MANUFACTURERS
TABLE 17 (CONTINUED)
DNA Microarrays—…(Continued)
FIGURE 5 MICROARRAYS IN GENE SYNTHESIS
DNA SEQUENCING TECHNOLOGIES
DNA Sequencing TECHNOLOGIES (continued)
FIGURE 6 SEQUENCING THROUGHPUT TREND, 1977-2008
FIGURE 7 DNA SEQUENCING TECHNOLOGIES
BIOINFORMATICS TECHNOLOGIES
TABLE 18 SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIES
BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS TECHNOLOGIES
TABLE 19 NUCLEIC ACIDS, GENES, AND GENOMES
SYNTHETIC GENES
TABLE 20 SYNTHETIC GENES AS MOLECULAR BIOLOGY TOOL
Synthetic Genes (Continued)
TABLE 21 SYNTHETIC GENES VERSUS PCR CLONING
BIOBRICKS/IGEM PARTS
TABLE 22 BIOBRICKS/IGEM PARTS
FIGURE 8 ROLE OF PROMOTERS AND REPORTERS IN SYNTHETIC BIOLOGY SYSTEMS
MINIMAL GENOMES AND CHASSIS ORGANISMS
TABLE 23 ATTRIBUTES OF A MINIMAL GENOME
Minimal Genomes and … (Continued)
CASE STUDY: MINIMAL E.COLI GENOME
Role of Directed Evolution in Designing Biologic Parts
ENABLED TECHNOLOGIES
OVERVIEW
TABLE 24 ENABLED TECHNOLOGIES: EXISTING AND NEAR-TERM APPLICATIONS
Pathway Engineering
FIGURE 9 HOW SYNTHETIC BIOLOGY CREATES ENABLED PRODUCTS
TABLE 25 METABOLIC ENGINEERING FOR ARTEMISINIC ACID
Synthetic Microbial Consortia
TABLE 26 APPLICATIONS FOR SYNTHETIC MICROBIAL CONSORTIA
BIOFUELS TECHNOLOGIES
Biofuels Feedstocks
TABLE 27 ENERGY BALANCE OF SELECTED FIRST-GENERATION BIOFUEL FEEDSTOCKS
Advanced-Generation Biofuels
TABLE 28 FIRST- AND ADVANCED-GENERATION BIOFUELS COMPARED
Cellulosic Biomass
FIGURE 10 APPROXIMATE COMPOSITION OF CELLULOSIC BIOMASS (%)
TABLE 29 SYNTHETIC BIOLOGY STRATEGIES FOR CONVERTING CELLULOSIC BIOMASS INTO ETHANOL
Biofuels Types
TABLE 30 EFFICIENCY OF VARIOUS FUELS
Cellulosic Ethanol
FIGURE 11 CELLULOSIC ETHANOL PRODUCTION SCHEMATIC
TABLE 31 CORN ETHANOL COST TARGETS, 2009 ($/GAL. OF ETHANOL)
FIGURE 12 ESTIMATED 25 MGY CELLULOSIC ETHANOL PLANT COSTS (%)
Biodiesel
TABLE 32 IODINE NUMBER OF VARIOUS OILS
Other Biofuels
Role of Genetic Engineering and Synthetic Biology in Biofuels
TABLE 33 CONTRIBUTION OF SYNTHETIC BIOLOGY TO BIOFUELS
CHAPTER FIVE: SYNTHETIC BIOLOGY APPLICATIONS
INTRODUCTION
ENABLING TECHNOLOGIES
TABLE 34 SYNTHETIC BIOLOGY PRODUCTS IMPACTED BY ENABLING TECHNOLOGIES
BIOLOGIC COMPONENTS AND INTEGRATED SYSTEMS APPLICATIONS
TABLE 35 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS NEAR-TERM APPLICATIONS
SYNTHETIC GENE APPLICATIONS
TABLE 36 SYNTHETIC GENES NEAR-TERM APPLICATIONS
Synthetic Gene Applications (Continued)
Synthetic Gene Applications (Continued)
BIOBRICKS/IGEM PARTS APPLICATIONS
INTEGRATED SYSTEMS APPLICATIONS
Synthetic Cells and Tissues
ENABLED PRODUCTS APPLICATIONS
TABLE 37 ENABLED PRODUCTS NEAR-TERM APPLICATIONS
APPLICATIONS BY END-USER INDUSTRY
RESEARCH AND DEVELOPMENT APPLICATIONS
TABLE 38 RESEARCH & DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS
PHARMACEUTICALS APPLICATIONS
TABLE 39 DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS
Pharmaceuticals Applications (Continued)
TABLE 40 PIPELINE OF SYNTHETIC BIOLOGY-ENABLED DRUGS
ENERGY APPLICATIONS
TABLE 41 ETHANOL AND BIODIESEL FEEDSTOCKS AND PRODUCTION PROCESSES
TABLE 42 ETHANOL AND BIODIESEL COMMON BLENDS
TABLE 43 FIRST-GENERATION FUEL ETHANOL GLOBAL PRODUCTION AND GOALS, 2007 (MILLION GALS.)
TABLE 44 FIRST-GENERATION BIODIESEL PRODUCTION AND GOALS, 2007 (MILLION GALS.)
United States
FIGURE 13 RENEWABLE FUELS STANDARDS, UNITED STATES, 2008-2013 (BILLION GALS./ YR)
TABLE 45 DOE FUNDING FOR CELLULOSIC BIOFUELS, 2007-2011 ($ MILLIONS)
Canada
Brazil
CHEMICAL INDUSTRY APPLICATIONS
Chemical Industry Applications (Continued)
CHAPTER SIX: SYNTHETIC BIOLOGY INDUSTRY
INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN
FIGURE 14 INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN WITH SYNTHETIC BIOLOGY LEVERAGE POINTS
INDUSTRY STRUCTURAL FORCES
TABLE 46 SYNTHETIC BIOLOGY INDUSTRY STRUCTURAL FORCES
INDUSTRY STRUCTURAL FORCES (CONTINUED)
PRODUCTS AND TECHNOLOGY LIFE CYCLE
TABLE 47 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
INDUSTRY COMPETITOR POSITIONING
TABLE 48 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
GENE SYNTHESIS INDUSTRY
GENE SYNTHESIS WORKFLOW
TABLE 49 GENE SYNTHESIS WORKFLOW
Gene Synthesis Workflow (Continued)
GENE SYNTHESIS COMPETITOR STRATEGIES
FIGURE 15 SYNTHETIC GENE COMPANY ESTIMATED MARKET SHARES, 2008 (%)
Gene Synthesis … (Continued)
TABLE 50 SYNTHETIC GENE KEY COMPETITOR STRATEGIES
Gene Synthesis … (Continued)
Gene Synthesis Value Chain
Synthetic Gene Market Segments
Automated, Standardized Market Segment
Value-Added Market Segments
TABLE 51 GENE SYNTHESIS MARKET FACTORS OF DIFFERENTIATION
BIOFUELS INDUSTRY
COMPETITIVE DIFFERENTIATION
FEEDSTOCKS
TABLE 52 BIOFUELS: FEEDSTOCKS, PRODUCTION, AND PRODUCTS
FIGURE 16 BIOFUELS FEEDSTOCKS: RELATIVE COSTS AND VOLUMES
Sugars/Starches
Vegetable Oils
Biomass
Algae
TABLE 53 BIODIESEL YIELD OF SELECTED CROPS (GALS./ACRE/YR.)
CO2
CELLULOSIC ETHANOL INDUSTRY
TABLE 54 CELLULOSIC ETHANOL PLANTS (MGY)
Cellulosic Ethanol Industry (Continued)
BIOFUELS COMPETITOR STRATEGIES
TABLE 55 SYNTHETIC BIOLOGY-BASED BIOFUELS COMPANY STRATEGIES
TABLE 55 (CONTINUED)
Agrivida
Amyris
BP 116
DuPont
Gevo
LS9
Mascoma
OpX Biotechnologies
Sequesco
Solazyme
Synthetic Genomics
Verdezyne
Verenium
ROLE OF BIOFUELS FOUNDERS AND INVESTORS
TABLE 56 ROLE OF INVESTORS AND FOUNDERS IN BIOFUELS COMPANIES
ENZYMES INDUSTRY
TABLE 57 ENZYME COMPANY KEY ALLIANCES
PHARMACEUTICALS INDUSTRY
TABLE 58 PHARMACEUTICALS COMPANY STRATEGIES
INDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCES
TABLE 59 INDUSTRY ACQUISITIONS, 2006-2008
TABLE 60 SYNTHETIC BIOLOGY STRATEGIC ALLIANCES, 2006-2009
TABLE 60 (CONTINUED)
TABLE 60 (CONTINUED)
BIODEFENSE ISSUES
TABLE 61 FUTURE SYNTHETIC BIOLOGY SECURITY REGULATIONS
SUPPORTING INDUSTRY ORGANIZATIONS
TABLE 62 SYNTHETIC BIOLOGY ENABLING ORGANIZATIONS
TABLE 62 (CONTINUED)
SUPPORTING INDUSTRY … (CONTINUED)
FIGURE 17 GROWTH IN IGEM (NUMBER)
CHAPTER SEVEN: SYNTHETIC BIOLOGY MARKETS
GROWTH DRIVING FORCES
TABLE 63 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
FIGURE 18 NIH BUDGET OUTLAYS, 2000-2009 ($ BILLIONS)
FIGURE 19 SYNTHETIC BIOLOGY RESEARCH PUBLICATIONS, 2000-2008 (NUMBER)
MARKET FORECASTS
FIGURE 20 MARKET FORECAST SCENARIO TABLE
SYNTHETIC BIOLOGY MARKETS BY INDUSTRY
Summary
TABLE 64 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER, THROUGH 2013 ($ MILLIONS)
R&D Market
TABLE 65 GLOBAL VALUE OF R&D MARKET BY APPLICATION, THROUGH 2013 ($ MILLIONS)
Biotechnology and Pharmaceuticals Market
TABLE 66 GLOBAL VALUE OF BIOTECHNOLOGY AND PHARMACEUTICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
Chemicals Market
TABLE 67 GLOBAL VALUE OF CHEMICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
Energy Market
TABLE 68 GLOBAL VALUE OF ENERGY MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
FIGURE 21 S-CURVE FOR SECOND-GENERATION BIOFUELS
TABLE 69 WORLD BIODIESEL PRODUCTION AND CAPACITY TRENDS, 2002-2008 (MILLIONS TONS/YR)
TABLE 70 GLOBAL BIOFUELS SUPPLY BY PRODUCT CLASS, THROUGH 2013 (KBOED)
FIGURE 22 GLOBAL BIOFUELS MARKET, 2013 (GALS./YR.)
FIGURE 22 (CONTINUED)
FIGURE 23 GLOBAL CELLULOSIC SECOND-GENERATION BIOFUELS MARKET, 2013 (GALS./YR)
FIGURE 23 (CONTINUED)
FIGURE 24 UNITED STATES BIOFUELS MARKET GOALS, 2022 (%)
SYNTHETIC BIOLOGY MARKETS BY PRODUCT TYPE
Summary
TABLE 71 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
Summary (Continued)
Enabling Products Market
TABLE 72 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLING PRODUCTS MARKET, THROUGH 2013 ($ MILLIONS)
Biological Parts Market
TABLE 73 GLOBAL VALUE OF DNA SYNTHESIS MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 74 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
Standardized Market Segment
Value-Added Market Segments
TABLE 75 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY END USER INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 76 GLOBAL VALUE OF BIOLOGIC PARTS BY SUPPLIER TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 77 HOMEBREW VERSUS COMMERCIAL COST COMPARISON FOR SYNTHESIZING A TYPICAL 714 BP GFP GENE ($)
Integrated Systems Market
TABLE 78 GLOBAL VALUE OF SYNTHETIC BIOLOGY INTEGRATED SYSTEMS MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
Enabled Products Market
TABLE 79 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED PRODUCTS MARKET BY INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 80 GLOBAL VALUE OF ENABLED R&D MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 81 GLOBAL VALUE OF ENABLED PHARMACEUTICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 82 GLOBAL VALUE OF ENABLED CHEMICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 82 (CONTINUED)
TABLE 83 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BY FUEL TYPE, THROUGH 2013 ($ MILLIONS)
SYNTHETIC BIOLOGY MARKET BY GEOGRAPHIC REGION
Summary
TABLE 84 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY GEOGRAPHIC REGION, THROUGH 2013 ($ MILLIONS)
Importance of Geography to Fuels Markets
Importance of Geography … (Continued)
CHAPTER EIGHT: PATENT STATUS
INTRODUCTION
FOUNDATIONAL PATENTS
TABLE 85 SYNTHETIC BIOLOGY FOUNDATIONAL PATENTS
SYNTHETIC BIOLOGY INDUSTRY PATENT ANALYSIS
SYNTHETIC BIOLOGY INDUSTRY (continued)
FIGURE 25 NUMBER OF PATENTS BY COMPANY
FIGURE 25 (CONTINUED)
TABLE 86 PATENT DESCRIPTION BY COMPANY
FIGURE 26 SYNTHETIC BIOLOGY PATENTS BY COMPANY AND SUBCLASS (NUMBER OF PATENTS)
FIGURE 26 (CONTINUED)
LITIGATION STATUS
TABLE 87 IP LITIGATION STATUS
IP STRATEGY OF SELECTED SYNTHETIC BIOLOGY COMPANIES
METABOLIX
DUPONT
GENEART
FEBIT
CHAPTER NINE: COMPANY PROFILES
AGRIVIDA
AMYRIS BIOTECHNOLOGIES, INC.
TABLE 88 AMYRIS BIODIESEL ADVANTAGES
ATG BIOSYNTHETICS GMBH
BASF AG
BIO BASIC, INC.
BIOCAT GMBH
BIONEER CORP.
BIONEXUS, INC.
BIO S&T, INC.
BIOTICA TECHNOLOGY, LTD.
BIOTICA TECHNOLOGY, LTD. (CONTINUED)
TABLE 89 STRUCTURE-FUNCTION APPROACH FOR RAPAMYCIN
TABLE 90 BIOTICA PROJECTS PIPELINE
BLUE HERON BIOTECHNOLOGIES
BRISTOL-MYERS SQUIBB
BRISTOL-MYERS SQUIBB (CONTINUED)
BRITISH PETROLEUM
CELLICON BIOTECHNOLOGIES, INC.
CODEXIS, INC
CODON DEVICES, INC.
DANISCO A/S
DNA 2.0
TABLE 91 DNA2.0 STRATEGIC ALLIANCES
DRATHS CORP
DUPONT
DUPONT (CONTINUED)
DYADIC INTERNATIONAL, INC.
ENTELECHON GMBH
EPOCH BIOLABS, INC.
ERAGEN BIOSCIENCES, INC.
EUROFINS MEDIGENOMIX GMBH
EUROFINS MWG OPERON
FEBIT SYNBIO GMBH
GENEART AG
TABLE 92 GENEART MAJOR STRATEGIC ALLIANCES
GENEART AG (CONTINUED)
GENEMED SYNTHESIS, INC.
GENSCRIPT CORP.
GENEWORKS PTY, LTD.
GEVO, INC.
TABLE 93 GEVO ISOBUTANOL PRODUCTION FORECAST (GALS./YR.)
HELICOS BIOSCIENCES CORP.
HELICOS BIOSCIENCES CORP. (CONTINUED)
HELICOS BIOSCIENCES CORP. (CONTINUED)
INTEGRATED DNA TECHNOLOGIES
ILLUMINA, INC.
ILLUMINA, INC. (CONTINUED)
INSTITUTE FOR ONEWORLD HEALTH
IOGEN CORP.
JOULE BIOTECHNOLOGIES, INC.
KHOSLA VENTURES
TABLE 94 KHOSLA VENTURES BIOFUELS INVESTMENT PORTFOLIO
LC SCIENCES
LIFE TECHNOLOGIES
LIFE TECHNOLOGIES (CONTINUED)
LS9, INC.
MASCOMA
TABLE 95 MASCOMA INTELLECTUAL PROPERTY STATUS
MAXYGEN
MERCK & CO.
METABOLIX, INC.
TABLE 96 METABOLOMIX BUSINESS STRATEGY
METRIGEN, INC.
NOVOZYMES A/S
OMEGA BIO-TEK, INC.
OPX BIOTECHNOLOGIES, INC.
PACIFIC BIOSCIENCES
PFIZER
PROTOLIFE SRL
QTEROS
ROCHE LIFE SCIENCES
ROCHE LIFE SCIENCES (CONTINUED)
ROYAL DSM N.V.
SANGAMO BIOSCIENCES, INC.
SANGAMO BIOSCIENCES, INC. (CONTINUED)
SANOFI AVENTIS
SCARAB GENOMICS, LLC
SEQUESCO
SLONING BIOTECHNOLOGY, GMBH
SOLAZYME, INC.
TABLE 97 SOLAZYME STRATEGIC ALLIANCES
SYNTHETIC GENOMICS
SYNTHETIC GENOMICS (CONTINUED)
TABLE 98 SYNTHETIC GENOMICS STRATEGIC ALLIANCES
VERDEZYNE
TABLE 99 VERDEZYNE STRATEGIC COLLABORATIONS
VERENIUM CORP.
VERENIUM CORP. (CONTINUED)
LIST OF TABLES
SUMMARY TABLE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 1 SCOPE OF THIS REPORT
TABLE 2 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
TABLE 3 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER, THROUGH 2013 ($ MILLIONS)
TABLE 4 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BY FUEL TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 5 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
TABLE 6 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
TABLE 7 SYNTHETIC BIOLOGY DEFINITIONS
TABLE 8 SYNTHETIC BIOLOGY HISTORY
TABLE 9 PARADIGM SHIFT OF BIOLOGY
TABLE 10 GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPARED
TABLE 11 SYNTHETIC BIOLOGY APPLICATIONS BY TECHNOLOGY
TABLE 12 IMPORTANCE OF ENABLING TECHNOLOGIES
TABLE 13 COMPARISON OF GENE SYNTHESIS TECHNOLOGIES
TABLE 14 IMPORTANCE OF MICROFLUIDICS TECHNOLOGIES IN SYNTHETIC BIOLOGY
TABLE 15 MICROARRAY TYPES
TABLE 16 DNA MICROARRAY PLATFORM FEATURES
TABLE 17 DNA MICROARRAY PLATFORM COMPARISON FOR MAJOR MANUFACTURERS
TABLE 18 SYNTHETIC BIOLOGY BIOINFORMATICS TECHNOLOGIES
TABLE 19 NUCLEIC ACIDS, GENES, AND GENOMES
TABLE 20 SYNTHETIC GENES AS MOLECULAR BIOLOGY TOOL
TABLE 21 SYNTHETIC GENES VERSUS PCR CLONING
TABLE 22 BIOBRICKS/IGEM PARTS
TABLE 23 ATTRIBUTES OF A MINIMAL GENOME
TABLE 24 ENABLED TECHNOLOGIES: EXISTING AND NEAR-TERM APPLICATIONS
TABLE 25 METABOLIC ENGINEERING FOR ARTEMISINIC ACID
TABLE 26 APPLICATIONS FOR SYNTHETIC MICROBIAL CONSORTIA
TABLE 27 ENERGY BALANCE OF SELECTED FIRST-GENERATION BIOFUEL FEEDSTOCKS
TABLE 28 FIRST- AND ADVANCED-GENERATION BIOFUELS COMPARED
TABLE 29 SYNTHETIC BIOLOGY STRATEGIES FOR CONVERTING CELLULOSIC BIOMASS INTO ETHANOL
TABLE 30 EFFICIENCY OF VARIOUS FUELS
TABLE 31 CORN ETHANOL COST TARGETS, 2009 ($/GAL. OF ETHANOL)
TABLE 32 IODINE NUMBER OF VARIOUS OILS
TABLE 33 CONTRIBUTION OF SYNTHETIC BIOLOGY TO BIOFUELS
TABLE 34 SYNTHETIC BIOLOGY PRODUCTS IMPACTED BY ENABLING TECHNOLOGIES
TABLE 35 BIOLOGICAL COMPONENTS AND INTEGRATED SYSTEMS NEAR-TERM APPLICATIONS
TABLE 36 SYNTHETIC GENES NEAR-TERM APPLICATIONS
TABLE 37 ENABLED PRODUCTS NEAR-TERM APPLICATIONS
TABLE 38 RESEARCH & DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS
TABLE 39 DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS FOR SYNTHETIC BIOLOGY PRODUCTS
TABLE 40 PIPELINE OF SYNTHETIC BIOLOGY-ENABLED DRUGS
TABLE 41 ETHANOL AND BIODIESEL FEEDSTOCKS AND PRODUCTION PROCESSES
TABLE 42 ETHANOL AND BIODIESEL COMMON BLENDS
TABLE 43 FIRST-GENERATION FUEL ETHANOL GLOBAL PRODUCTION AND GOALS, 2007 (MILLION GALS.)
TABLE 44 FIRST-GENERATION BIODIESEL PRODUCTION AND GOALS, 2007 (MILLION GALS.)
TABLE 45 DOE FUNDING FOR CELLULOSIC BIOFUELS, 2007-2011 ($ MILLIONS)
TABLE 46 SYNTHETIC BIOLOGY INDUSTRY STRUCTURAL FORCES
TABLE 47 SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
TABLE 48 SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
TABLE 49 GENE SYNTHESIS WORKFLOW
TABLE 50 SYNTHETIC GENE KEY COMPETITOR STRATEGIES
TABLE 51 GENE SYNTHESIS MARKET FACTORS OF DIFFERENTIATION
TABLE 52 BIOFUELS: FEEDSTOCKS, PRODUCTION, AND PRODUCTS
TABLE 53 BIODIESEL YIELD OF SELECTED CROPS (GALS./ACRE/YR.)
TABLE 54 CELLULOSIC ETHANOL PLANTS (MGY)
TABLE 55 SYNTHETIC BIOLOGY-BASED BIOFUELS COMPANY STRATEGIES
TABLE 56 ROLE OF INVESTORS AND FOUNDERS IN BIOFUELS COMPANIES
TABLE 57 ENZYME COMPANY KEY ALLIANCES
TABLE 58 PHARMACEUTICALS COMPANY STRATEGIES
TABLE 59 INDUSTRY ACQUISITIONS, 2006-2008
TABLE 60 SYNTHETIC BIOLOGY STRATEGIC ALLIANCES, 2006-2009
TABLE 61 FUTURE SYNTHETIC BIOLOGY SECURITY REGULATIONS
TABLE 62 SYNTHETIC BIOLOGY ENABLING ORGANIZATIONS
TABLE 63 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
TABLE 64 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER, THROUGH 2013 ($ MILLIONS)
TABLE 65 GLOBAL VALUE OF R&D MARKET BY APPLICATION, THROUGH 2013 ($ MILLIONS)
TABLE 66 GLOBAL VALUE OF BIOTECHNOLOGY AND PHARMACEUTICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 67 GLOBAL VALUE OF CHEMICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 68 GLOBAL VALUE OF ENERGY MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 69 WORLD BIODIESEL PRODUCTION AND CAPACITY TRENDS, 2002-2008 (MILLIONS TONS/YR)
TABLE 70 GLOBAL BIOFUELS SUPPLY BY PRODUCT CLASS, THROUGH 2013 (KBOED)
TABLE 71 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 72 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLING PRODUCTS MARKET, THROUGH 2013 ($ MILLIONS)
TABLE 73 GLOBAL VALUE OF DNA SYNTHESIS MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 74 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 75 GLOBAL VALUE OF BIOLOGIC PARTS MARKET BY END USER INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 76 GLOBAL VALUE OF BIOLOGIC PARTS BY SUPPLIER TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 77 HOMEBREW VERSUS COMMERCIAL COST COMPARISON FOR SYNTHESIZING A TYPICAL 714 BP GFP GENE ($)
TABLE 78 GLOBAL VALUE OF SYNTHETIC BIOLOGY INTEGRATED SYSTEMS MARKET BY TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 79 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED PRODUCTS MARKET BY INDUSTRY, THROUGH 2013 ($ MILLIONS)
TABLE 80 GLOBAL VALUE OF ENABLED R&D MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 81 GLOBAL VALUE OF ENABLED PHARMACEUTICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 82 GLOBAL VALUE OF ENABLED CHEMICALS MARKET BY PRODUCT TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 83 GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BY FUEL TYPE, THROUGH 2013 ($ MILLIONS)
TABLE 84 GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY GEOGRAPHIC REGION, THROUGH 2013 ($ MILLIONS)
TABLE 85 SYNTHETIC BIOLOGY FOUNDATIONAL PATENTS
TABLE 86 PATENT DESCRIPTION BY COMPANY
TABLE 87 IP LITIGATION STATUS
TABLE 88 AMYRIS BIODIESEL ADVANTAGES
TABLE 89 STRUCTURE-FUNCTION APPROACH FOR RAPAMYCIN
TABLE 90 BIOTICA PROJECTS PIPELINE
TABLE 91 DNA2.0 STRATEGIC ALLIANCES
TABLE 92 GENEART MAJOR STRATEGIC ALLIANCES
TABLE 93 GEVO ISOBUTANOL PRODUCTION FORECAST (GALS./YR.)
TABLE 94 KHOSLA VENTURES BIOFUELS INVESTMENT PORTFOLIO
TABLE 95 MASCOMA INTELLECTUAL PROPERTY STATUS
TABLE 96 METABOLOMIX BUSINESS STRATEGY
TABLE 97 SOLAZYME STRATEGIC ALLIANCES
TABLE 98 SYNTHETIC GENOMICS STRATEGIC ALLIANCES
TABLE 99 VERDEZYNE STRATEGIC COLLABORATIONS
LIST OF FIGURES
SUMMARY FIGURE GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY, 2006-2013 ($ MILLIONS)
FIGURE 1 SCALE OF SYNTHETIC BIOLOGY
FIGURE 2 DNA SYNTHESIS AND SEQUENCING COSTS, 1990-2008 ($)
FIGURE 3 HUMAN GENOME SEQUENCING COSTS, 1990-2015 ($)
FIGURE 4 SIMPLIFIED SCHEMATIC OF GENE SYNTHESIS TECHNOLOGY
FIGURE 5 MICROARRAYS IN GENE SYNTHESIS
FIGURE 6 SEQUENCING THROUGHPUT TREND, 1977-2008
FIGURE 7 DNA SEQUENCING TECHNOLOGIES
FIGURE 8 ROLE OF PROMOTERS AND REPORTERS IN SYNTHETIC BIOLOGY SYSTEMS
FIGURE 9 HOW SYNTHETIC BIOLOGY CREATES ENABLED PRODUCTS
FIGURE 10 APPROXIMATE COMPOSITION OF CELLULOSIC BIOMASS (%)
FIGURE 11 CELLULOSIC ETHANOL PRODUCTION SCHEMATIC
FIGURE 12 ESTIMATED 25 MGY CELLULOSIC ETHANOL PLANT COSTS (%)
FIGURE 13 RENEWABLE FUELS STANDARDS, UNITED STATES, 2008-2013 (BILLION GALS./ YR)
FIGURE 14 INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN WITH SYNTHETIC BIOLOGY LEVERAGE POINTS
FIGURE 15 SYNTHETIC GENE COMPANY ESTIMATED MARKET SHARES, 2008 (%)
FIGURE 16 BIOFUELS FEEDSTOCKS: RELATIVE COSTS AND VOLUMES
FIGURE 17 GROWTH IN IGEM
FIGURE 18 NIH BUDGET OUTLAYS, 2000-2009 ($ BILLIONS)
FIGURE 19 SYNTHETIC BIOLOGY RESEARCH PUBLICATIONS, 2000-2008 (NUMBER)
FIGURE 20 MARKET FORECAST SCENARIO TABLE
FIGURE 21 S-CURVE FOR SECOND-GENERATION BIOFUELS
FIGURE 22 GLOBAL BIOFUELS MARKET, 2013 (GALS./YR.)
FIGURE 23 2013 GLOBAL CELLULOSIC SECOND-GENERATION BIOFUELS MARKET (GALS./YR)
FIGURE 24 UNITED STATES BIOFUELS MARKET GOALS, 2022 (%)
FIGURE 25 NUMBER OF PATENTS BY COMPANY
FIGURE 26 SYNTHETIC BIOLOGY PATENTS BY COMPANY AND SUBCLASS (NUMBER OF PATENTS)
Latest Market Research Reports:
- Labeling and Linkage Agents for Immunoassays and Gene Probes
- Advanced Drug Delivery Systems: Technologies and Global Markets
- Global Market for Catalyst Regeneration
- Markets for Advanced Wound Care Technologies
- Wireless Sensors: Technologies and Global Markets
- Remote Sensing Technologies and Global Markets
- Portable Battery Powered Products: Global Markets
About Us:
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr. Priyank
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Visit Our Market Research Reports Blog
ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr. Priyank
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Visit Our Market Research Reports Blog
